Lean Body Mass as a Determinant of Docetaxel Pharmacokinetics and Toxicity
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer|Metastatic Castration-resistant Prostate Carcinoma
Interventions: OTHER: Lean body mass|OTHER: Total body weight|OTHER: bloodsampling
Sponsor: Radboud University Medical Center